Dr. Lal PathLabs Limited

₹2,009As of Sun 8 Nov 2026, 12:00 UTC
NSE:LALPATHLABHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 13.76%
Div yield 1.00%
ROE 22.61%
Diagnostics & Research
Beta (5Y) 0.20
PE TTM 57.60
TSR TTM 29.40%
Mkt cap ₹336.0B
ROIC 38.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹2,196
9.32%
(91.29%)
Hold 5|9|1|7|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
26.22
27.73
30.54
32.33
17.63%
11.35%
16.79%
22.52%
Revenue₹B
16.32
17.24
17.37
17.54
11.95%
16.02%
11.74%
8.09%
Peers (US$3.508B)
Cap (US$)
PE
3.999B
100.2x
1.613B
74.47x
4.128B
32.58x
Capital
TTM
5Y
10Y
Leveragex
0.478
0.396
0.309
EBIT/Intx
0.899
0.103
0.097
Own earn%
246.16
24.20
24.66
Sh yield%
39.92
34.15
27.19
Owners
Insiders/Inst%
2.76
87.57
Short interest%
2.79
SBC / revenue%
5.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
17–21
$1 testx
0.0
Incr. ROIC%
5